We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review).
- Authors
Umene, Kiyoko; Banno, Kouji; Kisu, Iori; Yanokura, Megumi; Nogami, Yuya; Tsuji, Kosuke; Masuda, Kenta; Ueki, Arisa; Kobayashi, Yusuke; Yamagami, Wataru; Nomura, Hiroyuki; Tominaga, Eiichiro; Susumu, Nobuyuki; Aoki, Daisuke
- Abstract
Subsequently to the publication of the above review article, the authors have realized that they made an error in terms of the description of the Aurora kinase inhibitor, ZM44739. Clinical applications of Aurora kinase inhibitors", on p. 337, right-hand column, lines 7-8, the authors wrote 'ZM447439 was reported as the first Aurora kinase inhibitor in 2003 and is currently in phase I clinical trials...'; however, a phase I clinical trial with this drug has not yet been conducted. Therefore, this sentence should be corrected to the following: 'ZM447439 was reported as the first Aurora kinase inhibitor in 2003'.
- Subjects
KINASE inhibitors; CANCER; AURORA kinases; CLINICAL drug trials
- Publication
Biomedical Reports, 2019, Vol 11, Issue 6, p274
- ISSN
2049-9434
- Publication type
Correction Notice
- DOI
10.3892/br.2019.1249